Cargando…
Neonatal clinical pharmacology and therapeutics /
Neonatal Clinical Pharmacology and Therapeutics.
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | , , |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Oxford [England] ; Boston :
Butterworth-Heinemann,
1991.
|
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000 a 4500 | ||
|---|---|---|---|
| 001 | SCIDIR_ocn551697313 | ||
| 003 | OCoLC | ||
| 005 | 20231117032858.0 | ||
| 006 | m o d | ||
| 007 | cr bn||||||abp | ||
| 007 | cr bn||||||ada | ||
| 008 | 100311s1991 enka ob 001 0 eng d | ||
| 040 | |a OCLCE |b eng |e pn |c OCLCE |d OCLCQ |d UIU |d OCLCQ |d OCLCF |d IDEBK |d N$T |d E7B |d YDXCP |d EBLCP |d HEBIS |d OCLCQ |d OCLCO |d OCLCA |d OCLCQ |d OCLCA |d MERUC |d OCLCO |d OCLCQ |d STF |d OCLCA |d YDX |d OCLCQ |d UKAHL |d OCLCA |d LUN |d OCLCQ |d OCLCA |d OCLCQ |d OCLCO |d OCLCQ |d OCL |d OCLCO | ||
| 019 | |a 651803723 |a 896795531 |a 974618874 |a 1091368723 |a 1091755398 |a 1100943012 |a 1153328673 |a 1154472975 | ||
| 020 | |a 9781483163000 |q (electronic bk.) | ||
| 020 | |a 1483163008 |q (electronic bk.) | ||
| 020 | |z 075061353X | ||
| 020 | |z 9780750613538 | ||
| 035 | |a (OCoLC)551697313 |z (OCoLC)651803723 |z (OCoLC)896795531 |z (OCoLC)974618874 |z (OCoLC)1091368723 |z (OCoLC)1091755398 |z (OCoLC)1100943012 |z (OCoLC)1153328673 |z (OCoLC)1154472975 | ||
| 042 | |a dlr | ||
| 050 | 4 | |a RG627.6.D79 |b N46 1991 | |
| 060 | 4 | |a WS 366 |b N4382 1991 | |
| 072 | 7 | |a MED |x 071000 |2 bisacsh | |
| 082 | 0 | 4 | |a 615.5/8 |2 20 |
| 084 | |a 44.38 |2 bcl | ||
| 084 | |a 44.67 |2 bcl | ||
| 245 | 0 | 0 | |a Neonatal clinical pharmacology and therapeutics / |c edited by George Rylance, David Harvey, Jacob V. Aranda. |
| 260 | |a Oxford [England] ; |a Boston : |b Butterworth-Heinemann, |c 1991. | ||
| 300 | |a 1 online resource (xi, 291 pages) : |b illustrations | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 504 | |a Includes bibliographical references and index. | ||
| 506 | |3 Use copy |f Restrictions unspecified |5 MiAaHDL |2 star | ||
| 533 | |a Electronic reproduction. |b [Place of publication not identified] : |c HathiTrust Digital Library, |d 2010. |5 MiAaHDL | ||
| 538 | |a Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002. |u http://purl.oclc.org/DLF/benchrepro0212 |5 MiAaHDL | ||
| 583 | 1 | |a digitized |c 2010 |h HathiTrust Digital Library |l committed to preserve |5 MiAaHDL |2 pda | |
| 588 | 0 | |a Print version record. | |
| 505 | 0 | |a Front Cover; Neonatal Clinical Pharmacology and Therapeutics; Copyright Page; Table of Contents; Contributors; Preface; Chapter 1. Pharmacological principles and kinetics; Drug-handling processes; Drug handling by the fetus; Pharmacokinetics and clinical relevance; Practical problems of drug delivery; References; Chapter 2. Placental transfer of drugs; Factors determining fetal dose; Measurement of placental transfer rate; Transfer of drugs in commonly presenting problems; Summary; References; Chapter 3. Drug therapy in pregnancy; Teratogenesis; Other effects of maternal drug therapy. | |
| 505 | 8 | |a Drugs affecting the cardiovascular systemAntimicrobials; References; Chapter 4. Tocolytics and oxytocin; Tocolytics; Magnesium Sulphate; Prostaglandin Synthetase Inhibitors; Calcium channel blockers; Alcohol; Oxytocin; References; Chapter 5. Maternal drug use and neonatal withdrawal; Drugs of abuse; Drug abuse and fertility; The risks of drug abuse to the pregnant mother; The risks of drug abuse to the fetus; The management of addiction in pregnancy; The management of labour; Neonatal withdrawal syndromes; Hepatitis and HIV; Breast Feeding; The children after discharge. | |
| 505 | 8 | |a The need for continuing researchReferences; Suggested further reading; Chapter 6. Prophylaxis for hyaline membrane disease; Primary prevention of prematurity; Pharmacological acceleration of lung development; References; Chapter 7. Maternal analgesia and anaesthesia and their effect on the newborn; Assessment of the neonate; Analgesia in labour; Anaesthesia; Sedatives in labour; References; Chapter 8. Treatment of neonatal apnoea; Methylxanthines: caffeine and theophylline; Doxapram; Almitrine; Other drugs; General considerations; References. | |
| 505 | 8 | |a Chapter 9. Prostaglandins and the perinatal pulmonary and systemic circulationProstaglandin synthesis; The arterial duct in the preterm infant; References; Chapter 10. Treatment of cardiac disorders in the neonate; Circulatory failure; Arrhythmias; Management of SVT; References; Chapter 11. Pharmacology of antibiotics in the newborn; Pharmacology of antibiotics in the newborn; Absorption, distribution and elimination of antibiotics; Pharmacokinetics; Therapeutic implications; Conclusion; References; Chapter 12. Drugs and neonatal jaundice; Drug treatment of unconjugated hyperbilirubinaemia. | |
| 505 | 8 | |a Drugs as contributors to jaundiceEffect of maternally-administered drugs; References; Chapter 13. Investigation and management of hypoglycaemia; Normal perinatal blood glucose metabolism; Hypoglycaemia; References; Chapter 14. Anticonvulsant drugs; Principles of anticonvulsant use; Drugs; References; Chapter 15. Pharmacology of vitamins A, D, E and K; Vitamin A; Vitamin D; Vitamin E (see also pp. 216-217); Vitamin K; References; Chapter 16. Oxygen transport by the blood, haematinics and blood cell component therapy in the neonate. | |
| 520 | |a Neonatal Clinical Pharmacology and Therapeutics. | ||
| 650 | 0 | |a Perinatal pharmacology. | |
| 650 | 0 | |a Newborn infants |x Effect of drugs on. | |
| 650 | 0 | |a Chemotherapy. | |
| 650 | 0 | |a Clinical pharmacology. | |
| 650 | 0 | |a Newborn infants. | |
| 650 | 0 | |a Pregnancy. | |
| 650 | 2 | |a Drug Therapy |0 (DNLM)D004358 | |
| 650 | 2 | |a Fetus |x drug effects |0 (DNLM)D005333Q000187 | |
| 650 | 2 | |a Pharmacology, Clinical |0 (DNLM)D010601 | |
| 650 | 2 | 2 | |a Infant, Newborn |0 (DNLM)D007231 |
| 650 | 2 | 2 | |a Pregnancy |0 (DNLM)D011247 |
| 650 | 6 | |a Pharmacologie p�erinatale. |0 (CaQQLa)201-0043581 | |
| 650 | 6 | |a Nouveau-n�es |x Effets des m�edicaments sur. |0 (CaQQLa)201-0132596 | |
| 650 | 6 | |a Chimioth�erapie. |0 (CaQQLa)201-0034750 | |
| 650 | 6 | |a Pharmacologie clinique. |0 (CaQQLa)201-0102967 | |
| 650 | 6 | |a Nouveau-n�es. |0 (CaQQLa)201-0015697 | |
| 650 | 6 | |a Grossesse. |0 (CaQQLa)201-0012998 | |
| 650 | 7 | |a pregnancy. |2 aat |0 (CStmoGRI)aat300189669 | |
| 650 | 7 | |a MEDICAL |x Pharmacology. |2 bisacsh | |
| 650 | 7 | |a Pregnancy |2 fast |0 (OCoLC)fst01075102 | |
| 650 | 7 | |a Newborn infants |2 fast |0 (OCoLC)fst01430819 | |
| 650 | 7 | |a Clinical pharmacology |2 fast |0 (OCoLC)fst00864398 | |
| 650 | 7 | |a Chemotherapy |2 fast |0 (OCoLC)fst00853595 | |
| 650 | 7 | |a Newborn infants |x Effect of drugs on |2 fast |0 (OCoLC)fst01430849 | |
| 650 | 7 | |a Perinatal pharmacology |2 fast |0 (OCoLC)fst01058040 | |
| 650 | 7 | |a Traitement m�edicamenteux |x Nouveau-n�e. |2 fmesh | |
| 650 | 7 | |a Traitement m�edicamenteux |x Grossesse. |2 fmesh | |
| 650 | 7 | |a Pharmacologie clinique. |2 fmesh | |
| 650 | 7 | |a Schwangerschaft |2 gnd |0 (DE-588)4053724-9 | |
| 650 | 7 | |a Pharmakotherapie |2 gnd |0 (DE-588)4076066-2 | |
| 650 | 7 | |a Aufsatzsammlung |2 gnd |0 (DE-588)4143413-4 | |
| 650 | 7 | |a Neugeborenenkrankheit |2 gnd |0 (DE-588)4041779-7 | |
| 650 | 7 | |a Fetopathie |2 gnd |0 (DE-588)4123206-9 | |
| 650 | 7 | |a Pharmacologie p�erinatale. |2 ram | |
| 650 | 7 | |a Nouveau-n�es |x Effets des m�edicaments. |2 ram | |
| 650 | 7 | |a Foetus |x Effets des m�edicaments. |2 ram | |
| 653 | |a Neonatal medicine | ||
| 653 | |a Pharmacology | ||
| 700 | 1 | |a Rylance, G. | |
| 700 | 1 | |a Harvey, David |q (David Robert) | |
| 700 | 1 | |a Aranda, Jacob V. | |
| 776 | 0 | 8 | |i Print version: |t Neonatal clinical pharmacology and therapeutics. |d Oxford [England] ; Boston : Butterworth-Heinemann, 1991 |w (DLC) 91020629 |w (OCoLC)23940238 |
| 856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/book/9780750613538 |z Texto completo |